SCHEMBL8237752

SCHEMBL8237752

CC(C)(C)OC(=O)Nc1cn(-c2ccccc2F)nc1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.41
GRM5 P41594 1/20 0.40
GRM1 Q13255 1/20 0.40
SCN9A Q15858 3/20 0.40
BRD9 Q9H8M2 1/20 0.40
CNR2 P34972 1/20 0.38
SLC6A9 P48067 1/20 0.38
KCNH2 Q12809 1/20 0.38
KMT2A Q03164 1/20 0.37
CYP17A1 P05093 1/20 0.37
RXFP1 Q9HBX9 1/20 0.36
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.36
P2RX7 Q99572 1/20 0.36
SCN5A Q14524 1/20 0.36
PIK3CD O00329 1/20 0.35
ABL1 P00519 1/20 0.35
EGFR P00533 1/20 0.35
KDR P35968 1/20 0.35
PIK3CA P42336 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1754340 0.83 HDAC1 (0.49) BRD9CNR2KMT2ALMNAPOLB
SCHEMBL4455302 0.81 ADORA1 (0.47) ADORA1SCN9AKMT2AGAANPSR1
SCHEMBL8243030 0.81 HDAC1 (0.51) GRM5GRM1BRD9KCNH2KMT2A
SCHEMBL8241599 0.80 GRM5 (0.42) GRM5GRM1BRD9CNR2CYP17A1
SCHEMBL12291158 0.77 KDM4E (0.43) BRD9CNR2RXFP1LMNAP2RX7
SCHEMBL8241813 0.77 CDK8 (0.41) ADORA1BRD9KMT2ALMNAPOLB
SCHEMBL8241611 0.77 BRD9 (0.42) ADORA1BRD9CNR2KMT2ALMNA
SCHEMBL12291140 0.76 KDM4E (0.41) KMT2ALMNAPOLBP2RX7GAA
SCHEMBL8174448 0.76 PARP1 (0.42) BRD9CNR2KMT2ALMNAP2RX7
SCHEMBL8241820 0.76 RXFP1 (0.50) KMT2ARXFP1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945617-B1 HISTONE DEACETYLASE INHIBITORS WITH ARYL-PYRAZOLYL MOTIFS MERCK SHARP & DOHME (US) 2012-12-26 EP disclosed
US-8026260-B2 Histone deacetylase inhibitors with aryl-pyrazolyl-motifs MERCK SHARP & DOHME CORP. (US) 2011-09-27 US disclosed
US-20090291965-A1 Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs MERCK SHARP & DOHME LLC 2009-11-26 US disclosed
WO-2007055941-A2 HISTONE DEACETYLASE INHIBITORS WITH ARYL-PYRAZOLYL MOTIFS MERCK & CO., INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291965-A1 Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs HDAC1, HDAC3, HDAC5 ADORA1 4380/4885GRM5 2465/4885GRM1 3328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.